Vertex Pharmaceuticals Inc (VRTX) — Financial Flexibility Index
Vertex Pharmaceuticals Inc (VRTX) has a Financial Flexibility Index of 0.22x as of March 2026. Free cash flow of $1.56 Billion (operating CF $1.43 Billion minus capex $133.40 Million) represents 0% of total liabilities ($7.12 Billion). Check asset allocation strategy of Vertex Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vertex Pharmaceuticals Inc Financial Flexibility Index (1991–2025)
Historical Financial Flexibility Index trend for Vertex Pharmaceuticals Inc across 35 annual periods. See Vertex Pharmaceuticals Inc (VRTX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Vertex Pharmaceuticals Inc (1991–2025)
Year-by-year free cash flow to debt coverage for Vertex Pharmaceuticals Inc. For the full company profile including market capitalisation, see Vertex Pharmaceuticals Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | $4.07 Billion | $3.63 Billion | $7.48 Billion | ▲ +1809.8% |
| 2024 | -0.03x | $-194.90 Million | $-492.60 Million | $6.12 Billion | ▼ -104.3% |
| 2023 | 0.74x | $3.80 Billion | $3.54 Billion | $5.15 Billion | ▼ -27.9% |
| 2022 | 1.02x | $4.33 Billion | $4.13 Billion | $4.24 Billion | ▲ +18.4% |
| 2021 | 0.86x | $2.88 Billion | $2.64 Billion | $3.33 Billion | ▼ -24.6% |
| 2020 | 1.15x | $3.51 Billion | $3.25 Billion | $3.06 Billion | ▲ +55.6% |
| 2019 | 0.74x | $1.64 Billion | $1.57 Billion | $2.23 Billion | ▼ -2.4% |
| 2018 | 0.75x | $1.37 Billion | $1.27 Billion | $1.81 Billion | ▲ +2.7% |
| 2017 | 0.73x | $1.10 Billion | $844.94 Million | $1.50 Billion | ▲ +290.4% |
| 2016 | 0.19x | $292.67 Million | $236.10 Million | $1.56 Billion | ▲ +182.5% |
| 2015 | -0.23x | $-320.13 Million | $-365.43 Million | $1.40 Billion | ▲ +38.9% |
| 2014 | -0.37x | $-462.00 Million | $-513.20 Million | $1.24 Billion | ▼ -202777.7% |
| 2013 | 0.00x | $-177.00K | $-51.57 Million | $962.64 Million | ▼ -100.1% |
| 2012 | 0.22x | $338.98 Million | $267.84 Million | $1.52 Billion | ▲ +15.5% |
| 2011 | 0.19x | $238.33 Million | $143.74 Million | $1.24 Billion | ▲ +139.3% |
| 2010 | -0.49x | $-597.39 Million | $-635.44 Million | $1.22 Billion | ▼ -4.0% |
| 2009 | -0.47x | $-404.09 Million | $-427.59 Million | $859.14 Million | ▼ -79.5% |
| 2008 | -0.26x | $-194.30 Million | $-226.48 Million | $741.61 Million | ▲ +60.7% |
| 2007 | -0.67x | $-220.06 Million | $-252.48 Million | $330.18 Million | ▼ -2886.4% |
| 2006 | 0.02x | $9.94 Million | $-22.48 Million | $415.64 Million | ▲ +104.8% |
| 2005 | -0.50x | $-155.09 Million | $-172.05 Million | $309.82 Million | ▼ -96.9% |
| 2004 | -0.25x | $-129.66 Million | $-142.16 Million | $510.01 Million | ▲ +10.1% |
| 2003 | -0.28x | $-150.27 Million | $-167.62 Million | $531.57 Million | ▼ -222.5% |
| 2002 | -0.09x | $-38.32 Million | $-79.54 Million | $437.14 Million | ▼ -186.0% |
| 2001 | 0.10x | $45.83 Million | $-8.07 Million | $449.78 Million | ▲ +1019.8% |
| 2000 | -0.01x | $-4.73 Million | $-16.64 Million | $427.12 Million | ▲ +98.4% |
| 1999 | -0.67x | $-15.60 Million | $-31.80 Million | $23.21 Million | ▲ +41.8% |
| 1998 | -1.15x | $-23.20 Million | $-31.10 Million | $20.10 Million | ▼ -565.4% |
| 1997 | -0.17x | $-3.40 Million | $-9.40 Million | $19.60 Million | ▲ +93.9% |
| 1996 | -2.86x | $-36.30 Million | $-40.30 Million | $12.70 Million | ▼ -269.4% |
| 1995 | -0.77x | $-10.60 Million | $-16.00 Million | $13.70 Million | ▲ +35.3% |
| 1994 | -1.20x | $-12.80 Million | $-14.70 Million | $10.70 Million | ▼ -232.3% |
| 1993 | 0.90x | $10.40 Million | $8.60 Million | $11.50 Million | ▲ +269.0% |
| 1992 | -0.54x | $-3.80 Million | $-5.30 Million | $7.10 Million | ▼ -101.7% |
| 1991 | -0.27x | $-1.30 Million | $-2.50 Million | $4.90 Million | — |